Table 1.
U251 secretome after treatment with pre-miR-93 or antagomiR-93
| Protein | Release (pg/ml) | Fold release after pre-miR-93 treatment | Fold release after antagomiR-93 treatment | miR-93 dependency (miR-93INDEX)a |
|---|---|---|---|---|
| PDGF-bb | 5.96 | 0.40 | 1.76 | 0.23 |
| IL-1ra | 475.02 | 0.49 | 0.80 | 0.61 |
| IL-2 | 3.84 | 1.32 | 0.62 | 2.10 |
| IL-6 | 85.8 | 0.39 | 1.28 | 0.30 |
| IL-7 | 4.17 | 0.38 | 1.64 | 0.23 |
| IL-8 | 838.38 | 0.27 | 1.63 | 0.17 |
| IL-9 | 3.53 | 0.59 | 1.47 | 0.40 |
| IL-10 | 25.15 | 0.48 | 1.57 | 0.30 |
| IL-12 | 105.99 | 0.46 | 1.59 | 0.29 |
| IL-15 | 9.60 | 0.72 | 0.40 | 1.80 |
| IL-17 | 14.80 | 0.50 | 1.09 | 0.47 |
| FGF | 49.55 | 0.52 | 1.33 | 0.39 |
| G-CSF | 6.30 | 0.53 | 1.37 | 0.39 |
| GM-CSF | 114.50 | 0.49 | 1.44 | 0.34 |
| IFN-γ | 14.47 | 0.36 | 1.32 | 0.27 |
| IP-10 | 7.80 | 0.45 | 1.37 | 0.33 |
| MCP-1(MCAF) | 4743.32 | 0.38 | 1.51 | 0.25 |
| MIP-1β | 2.35 | 0.59 | 1.27 | 0.47 |
| RANTES | 13.69 | 0.68 | 1.32 | 0.51 |
| TNF-α | 8.51 | 0.43 | 1.32 | 0.33 |
| VEGF | 9469.12 | 0.49 | 1.56 | 0.31 |
amiR-93 dependency: fold (pre-miR-93 treatment)/fold (antagomiR-93 treatment)